Effect of antiretroviral therapy on patients' economic well being: Five-year follow-up

AIDS

Volumn 28, Issue 3, 2014, Pages 417-424

  Rosen, Sydney ^a,b   Larson, Bruce ^a   Rohr, Julia ^a   Sanne, Ian ^b   Mongwenyana, Constance ^b   Brennan, Alana T ^a   Galárraga, Omar ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c BROWN UNIVERSITY   (United States)

Author keywords

Antiretroviral therapy; Economic outcomes; Employment; HIV AIDS; South Africa

Indexed keywords

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SOUTH AFRICA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84894040557     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000053     Document Type: Article

References (16)

1. Nash D, Katyal M, Brinkhof MWG, Keiser O, May M, Hughes R, et al. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS 2008; 22:2291-2302.
2. Etard J-F, Ndiaye I, Thierry-Mieg M, Guèye NFN, Guèye PM, Lanièce I, et al. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 2006; 20:1181-1189.
3. Floyd S, Molesworth A, Dube A, Banda E, Jahn A, Mwafulirwa C, et al. Population-level reduction in adult mortality after extension of free antiretroviral therapy provision into rural areas in northern Malawi. PloS One 2010; 5:e13499.
4. Gargano JW, Laserson K, Muttai H, Odhiam F, Orimba V, Adamu-zeh M, et al. The adult population impact of HIV care and antiretroviral therapy (ART)- Nyanza Province, Kenya, 2003-2008. AIDS 2012; 26:2003-2008.
5. Herbst AJ, Cooke GS, Bärnighausen T, Kanykany A, Tanser F, Newell M. Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ 2009; 87:754-762.
6. Beard J, Feeley F, Rosen S. Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review. AIDS Care 2009; 21:1343-1356.
7. Resch S, Korenromp E, Stover J, Blakley M, Krubiner C, Thorien K, et al. Economic returns to investment in AIDS treatment in low and middle income countries. PLoS One 2011; 6:e25310.
8. Rosen S, Larson B, Brennan A, Long L, Fox M, Mongwenyana C, et al. Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment. PLoS One 2010; 5:e12731.
9. Fox MP, Shearer K, Maskew M, Macleod W, Majuba P, MacPhail P, et al. Treatment outcomes after seven yers of public-sector HIV treatment at the Themba Lethu Clinic in Johannesburg, South Africa. AIDS 2012; 26:1823-1828.
10. Statistics South Africa. Mid-year population estimates 2011. http://www.statssa.gov.za/publications/P0302/P03022011.pdf. [Accessed 30 October 2012].
11. Johnson LF. Access to antiretroviral treatment in South Africa, 2004-2011. South Afr J HIV Med 2012; 2012:22-27.
12. Statistics South Africa. Quarterly Labour Force Survey Quarter 4, 2011. http://www.statssa.gov.za/publications/P0211/P02113rdQuarter2011.pdf. [Accessed 30 October 2012].
13. Kakinami L, de Bruyn G, Pronyk P, Mohapi L, Tshabangu N, Moshabela M, et al. The impact of highly active antiretroviral therapy on activities of daily living in HIV-infected adults in South Africa. AIDS Behav 2011; 15:823-831.
14. Weiser SD, Gupta R, Tsai AC, Frongillo EA, Grede N, Kumbakumba E, et al. Changes in food insecurity, nutritional status, and physical health status after antiretroviral therapy initiation in rural Uganda. J Acquir Immune Defic Syndr 2012; 61:179- 186.
15. Habyarimana J, Mbakile B, Pop-eleches C. The impact of HIV/AIDS and ARV treatment on worker absenteeism:implications for African firms. J Hum Resour 2010; 45:809-839.
16. Thirumirthy H, Zivin JG. Health and labor supply in the context of HIV/AIDS: the long run economic impacts of antiretroviral therapy. Econ Dev Cult Change 2012; 61:73-96.